Event‐free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa‐2b or hydroxyurea/best available therapy (PROUD‐PV/CONTINUATION‐PV)

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jean‐Jacques Kiladjian, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva‐Kyuchukova, Miklos Egyed, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiří Mayer, Vera Yablokova, Kurt Krejcy, Victoria Empson, Hans C. Hasselbalch, Robert Kralovics, Heinz Gisslinger
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	HemaSphere
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
DOI:	10.1002/hem3.70137

Similar Items